|
1
|
Senni M, Paulus WJ, Gavazzi A, Fraser AG,
Díez J, Solomon SD, Smiseth OA, Guazzi M, Lam CS, Maggioni AP, et
al: New strategies for heart failure with preserved ejection
fraction: the importance of targeted therapies for heart failure
phenotypes. Eur Heart J. 35:2797–2815. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hare JM, Fishman JE, Gerstenblith G,
Velazquez DL DiFede, Zambrano JP, Suncion VY, Tracy M, Ghersin E,
Johnston PV, Brinker JA, et al: Comparison of allogeneic vs
autologous bone marrow-derived mesenchymal stem cells delivered by
transendocardial injection in patients with ischemic
cardiomyopathy: the POSEIDON randomized trial. JAMA. 308:2369–2379.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Heldman AW, DiFede DL, Fishman JE,
Zambrano JP, Trachtenberg BH, Karantalis V, Mushtaq M, Williams AR,
Suncion VY, McNiece IK, et al: Transendocardial mesenchymal stem
cells and mononuclear bone marrow cells for ischemic
cardiomyopathy: the TAC-HFT randomized trial. JAMA. 311:62–73.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Perin EC, Willerson JT, Pepine CJ, Henry
TD, Ellis SG, Zhao DX, Silva GV, Lai D, Thomas JD, Kronenberg MW,
et al: Cardiovascular Cell Therapy Research Network (CCTRN): Effect
of transendocardial delivery of autologous bone marrow mononuclear
cells on functional capacity, left ventricular function, and
perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA.
307:1717–1726. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mathiasen AB, Jørgensen E, Qayyum AA,
Haack-Sørensen M, Ekblond A and Kastrup J: Rationale and design of
the first randomized, double-blind, placebo-controlled trial of
intramyocardial injection of autologous bone-marrow derived
mesenchymal stromal cells in chronic ischemic heart failure (MSC-HF
Trial). Am Heart J. 164:285–291. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Williams AR and Hare JM: Mesenchymal stem
cells: biology, pathophysiology, translational findings, and
therapeutic implications for cardiac disease. Circ Res.
109:923–940. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cao Y, Gomes SA, Rangel EB, Paulino EC,
Fonseca TL, Li J, Teixeira MB, Gouveia CH, Bianco AC, Kapiloff MS,
et al: S-nitrosoglutathione reductase-dependent PPARγ
denitrosylation participates in MSC-derived adipogenesis and
osteogenesis. J Clin Invest. 125:1679–1691. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Premer C, Blum A, Bellio MA, Schulman IH,
Hurwitz BE, Parker M, Dermarkarian CR, DiFede DL, Balkan W, Khan A,
et al: Allogeneic mesenchymal stem cells restore endothelial
function in heart failure by stimulating endothelial progenitor
cells. EBioMedicine. 2:467–475. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Castro-Manrreza ME, Mayani H,
Monroy-García A, Flores-Figueroa E, Chávez-Rueda K,
Legorreta-Haquet V, Santiago-Osorio E and Montesinos JJ: Human
mesenchymal stromal cells from adult and neonatal sources: a
comparative in vitro analysis of their immunosuppressive properties
against T cells. Stem Cells Dev. 23:1217–1232. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qu Z, Guo S, Fang G, Cui Z and Liu Y: AKT
pathway affects bone regeneration in nonunion treated with
umbilical cord-derived mesenchymal stem cells. Cell Biochem
Biophys. 71:1542–1551. 2014.
|
|
11
|
Qu Z, Guo L, Fang G, Cui Z, Guo S and Liu
Y: Biological characteristics and effect of human umbilical cord
mesenchymal stem cells (hUC-MSCs) grafting with blood plasma on
bone regeneration in rats. Cell Biochem Biophys. 63:171–181. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu Y, Shi ZL and Zhao Z: Transplantation
of human umbilical cord-derived mesenchymal stem cells improves
hepatic fibrosis in rats with carbon etrachloride-induced hepatic
cirrhosis. Chinese J Tissue Engineering Res. 16:1837–1840. 2012.(In
Chinese).
|
|
13
|
Qu Z, Fang G, Cui Z and Liu Y: Cell
therapy for bone nonunion: a retrospective study. Minerva Med.
106:315–321. 2015.PubMed/NCBI
|
|
14
|
Seth S, Bhargava B, Narang R, Ray R,
Mohanty S, Gulati G, Kumar L, Airan B and Venugopal P: AIIMS Stem
Cell Study Group: The ABCD (autologous bone marrow cells in dilated
cardiomyopathy) trial a long-term follow-up study. J Am Coll
Cardiol. 55:1643–1644. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fischer-Rasokat U, Assmus B, Seeger FH,
Honold J, Leistner D, Fichtlscherer S, Schächinger V, Tonn T,
Martin H, Dimmeler S, et al: A pilot trial to assess potential
effects of selective intracoronary bone marrow-derived progenitor
cell infusion in patients with nonischemic dilated cardiomyopathy:
final 1-year results of the transplantation of progenitor cells and
functional regeneration enhancement pilot trial in patients with
nonischemic dilated cardiomyopathy. Circ Heart Fail. 2:417–423.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gho JM, Kummeling GJ, Koudstaal S, Of
Lorkeers SJ Jansen, Doevendans PA, Asselbergs FW and Chamuleau SA:
Cell therapy, a novel remedy for dilated cardiomyopathy? A
systematic review. J Card Fail. 19:494–502. 2013. View Article : Google Scholar : PubMed/NCBI
|
